<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Microbiology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Microbiology</JournalTitle>
      <Issn>2008-3289</Issn>
      <Volume>4</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>06</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Molecular beacon probes-base multiplex NASBA Real-time for detection of HIV-1 and HCV</title>
    <FirstPage>47</FirstPage>
    <LastPage>54</LastPage>
    <AuthorList>
      <Author>
        <FirstName>S</FirstName>
        <LastName>Mohammadi-Yeganeh</LastName>
        <affiliation locale="en_US">Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. AND Molecular Biology and Genetic Engineering Department, Stem Cell Technology Research Center, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>M</FirstName>
        <LastName>Paryan</LastName>
        <affiliation locale="en_US">Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran. AND Molecular Biology and Genetic Engineering Department, Stem Cell Technology Research Center, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>S</FirstName>
        <LastName>Mirab Samiee</LastName>
        <affiliation locale="en_US">Day General Hospital Laboratory, Tehran, Iran. AND Food and Drug Laboratory Research Center, Ministry of Health and Medical Education, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>V</FirstName>
        <LastName>Kia</LastName>
        <affiliation locale="en_US">Department of Medical Biotechnology, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>H</FirstName>
        <LastName>Rezvan</LastName>
        <affiliation locale="en_US">Day General Hospital Laboratory, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background and Objectives: Developed in 1991, nucleic acid sequence-based amplification (NASBA) has been introduced as a rapid molecular diagnostic technique, where it has been shown to give quicker results than PCR, and it can also be more sensitive. This paper describes the development of a molecular beacon-based multiplex NASBA assay for simultaneous detection of HIV-1 and HCV in plasma samples.
Materials and Methods: A well-conserved region in the HIV-1 pol gene and 5&#x2019;-NCR of HCV genome were used for primers and molecular beacon design. The performance features of HCV/HIV-1 multiplex NASBA assay including analytical sensitivity and specificity, clinical sensitivity and clinical specificity were evaluated.
Results: The analysis of scalar concentrations of the samples indicated that the limit of quantification of the assay was &lt; 1000 copies/ml for HIV-1 and &lt; 500copies/ml for HCV with 95% confidence interval. Multiplex NASBA assay showed a 98% sensitivity and 100% specificity. The analytical specificity study with BLAST software demonstrated that the primers do not attach to any other sequences except for that of HIV-1 or HCV. The primers and molecular beacon probes detected all HCV genotypes and all major variants of HIV-1.
Conclusion: This method may represent a relatively inexpensive isothermal method for detection of HIV-1/HCV co-infection in monitoring of patients.</abstract>
    <web_url>https://ijm.tums.ac.ir/index.php/ijm/article/view/712</web_url>
    <pdf_url>https://ijm.tums.ac.ir/index.php/ijm/article/download/712/479</pdf_url>
  </Article>
</Articles>
